Results 61 to 70 of about 352,050 (202)
The Journal of Headache and Pain, 2021 Headache and facial pain are among the most common, disabling and costly diseases in Europe, which demands for high quality health care on all levels within the health system.
H. Schytz +19 more
semanticscholar +1 more source
Patients' preference for migraine preventive therapy
, 2007 Objective.-Preventive treatment is an important part of migraine therapy. When prescribing medication, physicians should understand patients' treatment preferences and select drugs that most closely meet their patients' needs.
Moreira, Frederico +13 more
core +1 more source
Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers [PDF]
, 2006 Sensitivity to light was investigated 5 and 8 h after consumption of an amino acid drink which contained L-tryptophan (balanced amino acid condition: 19 controls and 22 migraine sufferers) or which produced a short-term reduction in brain serotonin ...
Drummond, P.D.
core
Headache Medicine: updates and bibliometric analysis [PDF]
, 2022 Introduction Headache Medicine is the official scientific journal of the Brazilian Headache Society that has been publishing clinical and experimental, qualitative, and quantitative research on headaches and orofacial pain for 28 years, as well as ...
Peres, Mario Fernando Pietro +3 more
core +1 more source
Cephalalgia ReportsBackground Vestibular symptoms are a frequent and disabling manifestation of migraine, yet their underlying pathophysiology remains incompletely understood.
Alex Jaimes +5 more
doaj +1 more source
The Impact of Biseasonal Time Changes on Migraine
Neurology InternationalBackground: Changes in the daily rhythm can trigger migraine attacks. The sensitivity for triggering attacks is closely linked to the regulation of biological rhythms controlled by the hypothalamus.
Carl H. Göbel +4 more
doaj +1 more source
Real world preventative drug management of migraine among Spanish neurologists
The Journal of Headache and Pain, 2019 Background Many different preventatives have showed efficacy in the treatment of migraine. National guidelines differ in their recommendations and patients’ characteristics are usually taken into account in their selection.
D. García-Azorin +4 more
doaj +1 more source
The Journal of Headache and Pain, 2020 Introduction Headache is one of the most frequent neurologic manifestations in COVID-19. We aimed to analyze which symptoms and laboratory abnormalities were associated with the presence of headache and to evaluate if patients with headache had a higher ...
Javier Trigo +17 more
semanticscholar +1 more source
Trial of Galcanezumab in Prevention of Episodic Cluster Headache.
New England Journal of Medicine, 2019 BACKGROUND Episodic cluster headache is a disabling neurologic disorder that is characterized by daily headache attacks that occur over periods of weeks or months. Galcanezumab, a humanized monoclonal antibody to calcitonin gene-related peptide, may be a
P. Goadsby +12 more
semanticscholar +1 more source
How do clinicians think about cluster headache [PDF]
, 2016 Background: We have little in-depth understanding of how clinicians perceive cluster headache and of their experiences with cluster headache patients.
Ahmed, F. +3 more
core